新功能、新界面、新体验,扫描即可下载生物谷APP!
首页 » 仿制药市场 » 第一三共推出5款新的仿制药

第一三共推出5款新的仿制药

来源:生物谷 2012-12-29 03:29

2012年12月28日 讯 /生物谷BIOON/ --第一三共(Daiichi Sankyo)宣布,旗下子公司Daiichi Sankyo Espha将推出5款包含2种活性成分的新的仿制药,分别为抗精神病药物喹硫平片(Quetiapine,25mg、100mg、200mg)及胃病药物消化道促动力剂枸橼酸莫沙必利片(Mosapride Citrate,2.5mg、5mg)。(生物谷bioon.com)

英文原文:

Daiichi Sankyo Espha to launch five new generic drugs
Comtex News Network
Dec 24, 2012 (Datamonitor via COMTEX) -- Daiichi Sankyo Company, Limited has announced that its Japanese established pharmaceuticals subsidiary, Daiichi Sankyo Espha Company, Limited, will launch five generic products with two active ingredients.

Daiichi Sankyo Espha will launch Quetiapine tablets in 25 mg, 100 mg and 200 mg DSEP formulations.

Quetiapine tablet is used as an antipsychotic.

It will also launch Mosapride Citrate tablets 2.5 mg DSEP, gastroprokinetic agent.

The company also announced the launch of Mosapride Citrate tablets 5 mg DSEP, gastroprokinetic agent.

温馨提示:87%用户都在生物谷APP上阅读,扫描立刻下载! 天天精彩!


相关标签

最新会议 培训班 期刊库